{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T17:41:12Z","timestamp":1791222072833,"version":"4.1.0"},"reference-count":7,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,1,21]]},"DOI":"10.7759\/cureus.77797","type":"journal-article","created":{"date-parts":[[2025,1,22]],"date-time":"2025-01-22T02:46:57Z","timestamp":1737514017000},"source":"Crossref","is-referenced-by-count":5,"title":["Acute Myocarditis Following Dupilumab Initiation"],"prefix":"10.7759","author":[{"given":"Samrita","family":"Naidu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rani","family":"Vatti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/S0046-8177(81)80195-5","article-title":"Drug related myocarditis: I. Hypersensitivity myocarditis","volume":"12","author":"Fenoglio JJ","year":"1981","unstructured":"Fenoglio JJ, McAllister HA, Mullick FG. Drug related myocarditis: I. Hypersensitivity myocarditis. Hum Pathol. 1981, 12:900-7. 10.1016\/S0046-8177(81)80195-5","journal-title":"Hum Pathol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1111\/cts.13899","article-title":"Dupilumab: mechanism of action, clinical, and translational science","volume":"17","author":"McCann MR","year":"2024","unstructured":"McCann MR, Kosloski MP, Xu C, Davis JD, Kamal MA. Dupilumab: mechanism of action, clinical, and translational science. Clin Transl Sci. 2024, 17:e13899. 10.1111\/cts.13899","journal-title":"Clin Transl Sci"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1080\/14740338.2024.2326480","article-title":"Dupilumab in real-life settings: a review of adverse events and their pathogenesis","volume":"23","author":"Camela E","year":"2024","unstructured":"Camela E, Giampetruzzi AR, De Pit\u00e0 O, Pallotta S, Russo F. Dupilumab in real-life settings: a review of adverse events and their pathogenesis. Expert Opin Drug Saf. 2024, 23:439-47. 10.1080\/14740338.2024.2326480","journal-title":"Expert Opin Drug Saf"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.17177","article-title":"Dupilumab-associated hypereosinophilia in patients treated for moderate-to-severe atopic dermatitis","volume":"35","author":"Marcant P","year":"2021","unstructured":"Marcant P, Balay\u00e9 P, Merhi R, et al.. Dupilumab-associated hypereosinophilia in patients treated for moderate-to-severe atopic dermatitis. J Eur Acad Dermatol Venereol. 2021, 35:e394-6. 10.1111\/jdv.17177","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1111\/all.14964","article-title":"Eosinophilic pleural effusion and stroke with cutaneous vasculitis: two cases of dupilumab-induced hypereosinophilia","volume":"76","author":"Lommatzsch M","year":"2021","unstructured":"Lommatzsch M, Stoll P, Winkler J, Zeise-Wehry D, Tronnier M, Weber MA, Virchow JC. Eosinophilic pleural effusion and stroke with cutaneous vasculitis: two cases of dupilumab-induced hypereosinophilia. Allergy. 2021, 76:2920-3. 10.1111\/all.14964","journal-title":"Allergy"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.anai.2022.08.754","article-title":"Dupilumab induced hypereosinophilic syndrome (HES)","volume":"129","author":"Abulhamail A","year":"2022","unstructured":"Abulhamail A, Kelbel T, Lin J, Funderburk L. Dupilumab induced hypereosinophilic syndrome (HES). Ann Allergy Asthma Immunol. 2022, 129:90-1. 10.1016\/j.anai.2022.08.754","journal-title":"Ann Allergy Asthma Immunol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacig.2022.03.006","article-title":"Eosinophilic granulomatosis with polyangiitis after treatment with dupilumab","volume":"1","author":"Yamazaki K","year":"2022","unstructured":"Yamazaki K, Nomizo T, Hatanaka K, Hayama N, Oguma T, Asano K. Eosinophilic granulomatosis with polyangiitis after treatment with dupilumab. J Allergy Clin Immunol Glob. 2022, 1:180-2. 10.1016\/j.jacig.2022.03.006","journal-title":"J Allergy Clin Immunol Glob"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/336139-acute-myocarditis-following-dupilumab-initiation","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,22]],"date-time":"2025-01-22T02:46:59Z","timestamp":1737514019000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/336139-acute-myocarditis-following-dupilumab-initiation"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,21]]},"references-count":7,"URL":"https:\/\/doi.org\/10.7759\/cureus.77797","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1,21]]}}}